Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency (STAMP)
This study has been completed.
Study NCT00301366 Information provided by Grifols Therapeutics Inc.
First Received on March 8, 2006. Last Updated on September 26, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alpha 1-Antitrypsin Deficiency
More general conditions related to this trial
Digestive System Diseases
Genetic Diseases, Inborn
Respiratory Tract Diseases
Additional drug interventions recognized in this trial
Protein C Inhibitor
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Serine Proteinase Inhibitors
Sponsors listed in this trial
Grifols Therapeutics Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers